Chromatin context dominates estrogen regulation of pS2 gene expression

Experimental Cell Research

Volumn 314, Issue 15, 2008, Pages 2796-2810

  Oduro, Akua K ^a   Fritsch, Michael K ^a   Murdoch, Fern E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chromatin; Estrogen receptor; flp recombination target; Histone acetylation; Histone methylation; Nuclear receptors; pS2; Steroid receptors

Indexed keywords

BETA GALACTOSIDASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; LUCIFERASE; LYSINE; PROTEIN PS2; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MODIFICATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE BINDING; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 50049127216     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.006     Document Type: Article

References (70)

1. Knezetic J.A., and Luse D.S. The presence of nucleosomes on a DNA template prevents initiation by RNA polymerase II in vitro. Cell 45 (1986) 95-104
2. Lorch Y., LaPointe J.W., and Kornberg R.D. Nucleosomes inhibit the initiation of transcription but allow chain elongation with the displacement of histones. Cell 49 (1987) 203-210
3. O'Neill T.E., Roberge M., and Bradbury E.M. Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase. J. Mol. Biol. 223 (1992) 67-78
4. Laybourn P.J., and Kadonaga J.T. Role of nucleosomal cores and histone H1 in regulation of transcription by RNA polymerase II. Science 254 (1991) 238-245
5. Rice J.C., Briggs S.D., Ueberheide B., Barber C.M., Shabanowitz J., Hunt D.F., Shinkai Y., and Allis C.D. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12 (2003) 1591-1598
6. Roh T.Y., Cuddapah S., and Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev. 19 (2005) 542-552
7. Tse C., Sera T., Wolffe A.P., and Hansen J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell Biol. 18 (1998) 4629-4638
8. Nightingale K.P., Wellinger R.E., Sogo J.M., and Becker P.B. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin. Embo. J. 17 (1998) 2865-2876
9. Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E., Emre N.C., Schreiber S.L., Mellor J., and Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature 419 (2002) 407-411
10. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., McMahon S., Karlsson E.K., Kulbokas III E.J., Gingeras T.R., Schreiber S.L., and Lander E.S. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120 (2005) 169-181
11. Peterson C.L., and Laniel M.A. Histones and histone modifications. Curr. Biol. 14 (2004) R546-551
12. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12 (2002) 142-148
13. Wolffe A.P. Histone deacetylase: a regulator of transcription. Science 272 (1996) 371-372
14. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
15. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
16. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
17. Feinberg A.P. The epigenetics of cancer etiology. Semin. Cancer Biol. 14 (2004) 427-432
18. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., and Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 (2002) 624-629
19. Rice K.L., Hormaeche I., and Licht J.D. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 26 (2007) 6697-6714
20. Weidman J.R., Dolinoy D.C., Murphy S.K., and Jirtle R.L. Cancer susceptibility: epigenetic manifestation of environmental exposures. Cancer J. 13 (2007) 9-16
21. Bruserud O., Stapnes C., Tronstad K.J., Ryningen A., Anensen N., and Gjertsen B.T. Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert Opin. Ther. Targets 10 (2006) 51-68
22. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., Weiss S.J., Rubin M.A., and Chinnaiyan A.M. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U S A 100 (2003) 11606-11611
23. Manni A., Arafah B., and Pearson O.H. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Cancer 46 (1980) 2838-2841
24. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
25. Prest S.J., May F.E., and Westley B.R. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. Faseb. J. 16 (2002) 592-594
26. Abba M.C., Hu Y., Sun H., Drake J.A., Gaddis S., Baggerly K., Sahin A., and Aldaz C.M. Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 6 (2005) 37
27. West M., Blanchette C., Dressman H., Huang E., Ishida S., Spang R., Zuzan H., Olson Jr. J.A., Marks J.R., and Nevins J.R. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. U S A 98 (2001) 11462-11467
28. Tozlu S., Girault I., Vacher S., Vendrell J., Andrieu C., Spyratos F., Cohen P., Lidereau R., and Bieche I. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr. Relat. Cancer 13 (2006) 1109-1120
29. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr. Relat. Cancer 13 (2006) 1033-1067
30. Yan C., and Boyd D.D. Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol. Cell Biol. 26 (2006) 6357-6371
31. Beato M., and Klug J. Steroid hormone receptors: an update. Hum. Reprod. Update 6 (2000) 225-236
32. Robyr D., and Wolffe P. Hormone action and chromatin remodelling. Cell Mol. Life Sci. 54 (1998) 113-124
33. Kishimoto M., Fujiki R., Takezawa S., Sasaki Y., Nakamura T., Yamaoka K., Kitagawa H., and Kato S. Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr. J. 53 (2006) 157-172
34. Lee E.R., McCool K.W., Murdoch F.E., and Fritsch M.K. Dynamic changes in histone H3 phosphoacetylation during early embryonic stem cell differentiation are directly mediated by mitogen- and stress-activated protein kinase 1 via activation of MAPK pathways. J. Biol. Chem. 281 (2006) 21162-21172
35. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25 (2001) 402-408
36. Weinmann A.S., and Farnham P.J. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26 (2002) 37-47
37. Rao S., Procko E., and Shannon M.F. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167 (2001) 4494-4503
38. Francis J., Babu D.A., Deering T.G., Chakrabarti S.K., Garmey J.C., Evans-Molina C., Taylor D.G., and Mirmira R.G. Role of chromatin accessibility in the occupancy and transcription of the insulin gene by the pancreatic and duodenal homeobox factor 1. Mol. Endocrinol. 20 (2006) 3133-3145
39. Okino S.T., and Whitlock Jr. J.P. Dioxin induces localized, graded changes in chromatin structure: implications for Cyp1A1 gene transcription. Mol. Cell Biol. 15 (1995) 3714-3721
40. Yan C., Wang H., Aggarwal B., and Boyd D.D. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. Faseb. J. 18 (2004) 540-541
41. Wiseman L.R., Wakeling A.E., May F.E., and Westley B.R. Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells. J. Steroid Biochem. 33 (1989) 1-6
42. Valley C.C., Metivier R., Solodin N.M., Fowler A.M., Mashek M.T., Hill L., and Alarid E.T. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. Mol. Cell Biol. 25 (2005) 5417-5428
43. Preisler-Mashek M.T., Solodin N., Stark B.L., Tyriver M.K., and Alarid E.T. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E891-898
44. Berry M., Nunez A.M., and Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. U S A 86 (1989) 1218-1222
45. Shang Y., Hu X., DiRenzo J., Lazar M.A., and Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 (2000) 843-852
46. Wagner S., Weber S., Kleinschmidt M.A., Nagata K., and Bauer U.M. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. J. Biol. Chem. 281 (2006) 27242-27250
47. Nunez A.M., Berry M., Imler J.L., and Chambon P. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. Embo. J. 8 (1989) 823-829
48. Coleman K.M., and Smith C.L. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 6 (2001) D1379-1391
49. Wolffe A.P., and Guschin D. Review: chromatin structural features and targets that regulate transcription. J. Struct. Biol. 129 (2000) 102-122
50. Norton V.G., Imai B.S., Yau P., and Bradbury E.M. Histone acetylation reduces nucleosome core particle linking number change. Cell 57 (1989) 449-457
51. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179
52. Gregory R.I., O'Neill L.P., Randall T.E., Fournier C., Khosla S., Turner B.M., and Feil R. Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. J. Biol. Chem. 277 (2002) 11728-11734
53. McCool K.W., Xu X., Singer D.B., Murdoch F.E., and Fritsch M.K. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. J. Biol. Chem. 282 (2007) 6696-6706
54. Wakimoto B.T. Beyond the nucleosome: epigenetic aspects of position-effect variegation in Drosophila. Cell 93 (1998) 321-324
55. Guy L.G., Kothary R., DeRepentigny Y., Delvoye N., Ellis J., and Wall L. The beta-globin locus control region enhances transcription of but does not confer position-independent expression onto the lacZ gene in transgenic mice. Embo. J. 15 (1996) 3713-3721
56. Lewis E.B. The phenomenon of position effect. Adv. Genet. 3 (1950) 73-115
57. Leo C., and Chen J.D. The SRC family of nuclear receptor coactivators. Gene 245 (2000) 1-11
58. Lu H., Pise-Masison C.A., Fletcher T.M., Schiltz R.L., Nagaich A.K., Radonovich M., Hager G., Cole P.A., and Brady J.N. Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template. Mol. Cell Biol. 22 (2002) 4450-4462
59. Biswas D., Imbalzano A.N., Eriksson P., Yu Y., and Stillman D.J. Role for Nhp6, Gcn5, and the Swi/Snf complex in stimulating formation of the TATA-binding protein-TFIIA-DNA complex. Mol. Cell Biol. 24 (2004) 8312-8321
60. Sewack G.F., Ellis T.W., and Hansen U. Binding of TATA binding protein to a naturally positioned nucleosome is facilitated by histone acetylation. Mol. Cell Biol. 21 (2001) 1404-1415
61. Wang C., Fu M., Angeletti R.H., Siconolfi-Baez L., Reutens A.T., Albanese C., Lisanti M.P., Katzenellenbogen B.S., Kato S., Hopp T., Fuqua S.A., Lopez G.N., Kushner P.J., and Pestell R.G. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J. Biol. Chem. 276 (2001) 18375-18383
62. Fu M., Wang C., Reutens A.T., Wang J., Angeletti R.H., Siconolfi-Baez L., Ogryzko V., Avantaggiati M.L., and Pestell R.G. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 275 (2000) 20853-20860
63. Popov V.M., Wang C., Shirley L.A., Rosenberg A., Li S., Nevalainen M., Fu M., and Pestell R.G. The functional significance of nuclear receptor acetylation. Steroids 72 (2007) 221-230
64. Kim M.Y., Woo E.M., Chong Y.T., Homenko D.R., and Kraus W.L. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 20 (2006) 1479-1493
65. Almer A., Rudolph H., Hinnen A., and Horz W. Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements. Embo. J. 5 (1986) 2689-2696
66. Belikov S., Gelius B., Almouzni G., and Wrange O. Hormone activation induces nucleosome positioning in vivo. Embo. J. 19 (2000) 1023-1033
67. Reik A., Schutz G., and Stewart A.F. Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: induction leads to a reversible disruption of nucleosomes over an enhancer. Embo. J. 10 (1991) 2569-2576
68. Angelov D., Charra M., Seve M., Cote J., Khochbin S., and Dimitrov S. Differential remodeling of the HIV-1 nucleosome upon transcription activators and SWI/SNF complex binding. J. Mol. Biol. 302 (2000) 315-326
69. Massarweh S., and Schiff R. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities. Clin. Cancer Res. 13 (2007) 1950-1954
70. Kurebayashi J. Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance. Breast Cancer 10 (2003) 112-119